Updated neurophysiology of itch

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 8, 2013, Pages 1235-1240

  Ikoma, Akihiko ^a  

^a Takenaka Research and Development Institute   (Japan)

Author keywords

Itch sensitization; Neuropathic itch; Pruritogen; Spinal receptor

Indexed keywords

ACETYLCHOLINE; CHLOROQUINE; DYNORPHIN; ENDORPHIN; GASTRIN RELEASING PEPTIDE; INTERLEUKIN 31; KAPPA OPIATE RECEPTOR AGONIST; MESSENGER RNA; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NALFURAFINE; NALOXONE; NALTREXONE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; SUBSTANCE P;

ACETYLCHOLINE RELEASE; ALLODYNIA; ARTICLE; ATOPIC DERMATITIS; CAUSAL ATTRIBUTION; DRUG EFFICACY; DRUG RESPONSE; HISTAMINE RELEASE; HUMAN; HYPERALGESIA; KERATINOCYTE; NERVE CELL; NERVE ENDING; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHIC ITCH; NEUROTRANSMISSION; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PRURITUS; SENSORY NERVE CELL; STIMULUS RESPONSE;

EID: 84883203408     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00435     Document Type: Article

References (70)

1. Ikoma A, Steinhoff M, Ständer S, Yosipovitch G, Schmelz M. The neurobiology of itch. Nat. Rev. Neurosci., 7, 535-547 (2006).
2. Schmelz M, Schmidt R, Bickel A, Handwerker HO, Torebjörk HE. Specific C-receptors for itch in human skin. J. Neurosci., 17, 8003-8008 (1997).
3. Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine: a central neural pathway for itch. Nat. Neurosci., 4, 72-77 (2001).
4. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science, 325, 1531-1534 (2009).
5. Wilson SR, Gerhold KA, Bifolck-Fisher A, Liu Q, Patel KN, Dong X, Bautista DM. TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat. Neurosci., 14, 595-602 (2011).
6. Namer B, Carr R, Johanek LM, Schmelz M, Handwerker HO, Ringkamp M. Separate peripheral pathways for pruritus in man. J. Neurophysiol., 100, 2062-2069 (2008).
7. Reddy VB, Iuga AO, Shimada SG, LaMotte RH, Lerner EA. Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors. J. Neurosci., 28, 4331-4335 (2008).
8. Ikoma A, Handwerker H, Miyachi Y, Schmelz M. Electrically evoked itch in humans. Pain, 113, 148-154 (2005).
9. Kosteletzky F, Namer B, Forster C, Handwerker HO. Impact of scratching on itch and sympathetic reflexes induced by cowhage (Mucuna pruriens) and histamine. Acta Derm. Venereol., 89, 271-277 (2009).
10. Sikand P, Shimada SG, Green BG, LaMotte RH. Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage. Pain, 144, 66-75 (2009).
11. Seo YJ, Kwon MS, Shim EJ, Park SH, Choi OS, Suh HW. Changes in pain behavior induced by formalin, substance P, glutamate and pro-inflammatory cytokines in immobilization-induced stress mouse model. Brain Res. Bull., 71, 279-286 (2006).
12. Shimada SG, LaMotte RH. Behavioral differentiation between itch and pain in mouse. Pain, 139, 681-687 (2008).
13. Fukuoka M, Miyachi Y, Ikoma A. Mechanically evoked itch in humans. Pain, 154, 897-904 (2013).
14. Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J. Invest. Dermatol., 130, 1023-1033 (2010).
15. Steinhoff M, Neisius U, Ikoma A, Fartasch M, Heyer G, Skov PS, Luger TA, Schmelz M. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J. Neurosci., 23, 6176-6180 (2003).
16. Schmelz M. Itch - mediators and mechanisms. J. Dermatol. Sci., 28, 91-96 (2002).
17. 2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J. Am. Acad. Dermatol., 47, 28-32 (2002).
18. Vogelsang M, Heyer G, Hornstein OP. Acetylcholine induces different cutaneous sensations in atopic and non-atopic subjects. Acta Derm. Venereol., 75, 434-436 (1995).
19. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, Haugen HS, Maurer M, Harder B, Johnston J, Bort S, Mudri S, Kuijper JL, Bukowski T, Shea P, Dong DL, Dasovich M, Grant FJ, Lockwood L, Levin SD, LeCiel C, Waggie K, Day H, Topouzis S, Kramer J, Kuestner R, Chen Z, Foster D, Parrish-Novak J, Gross JA. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat. Immunol., 5, 752-760 (2004).
20. Ballantyne JC, Loach AB, Carr DB. Itching after epidural and spinal opiates. Pain, 33, 149-160 (1988).
21. Mikuni I, Hirai H, Toyama Y, Takahata O, Iwasaki H. Efficacy of intrathecal morphine with epidural ropivacaine infusion for postcesarean analgesia. J. Clin. Anesth., 22, 268-273 (2010).
22. Rosow CE, Moss J, Philbin DM, Savarese JJ. Histamine release during morphine and fentanyl anesthesia. Anesthesiology, 56, 93-96 (1982).
23. Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth. Analg., 98, 364-370 (2004).
24. Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br. Med. J. (Clin. Res. Ed.), 287, 1199-1200 (1983).
25. Bromage PR, Camporesi EM, Durant PA, Nielsen CH. Rostral spread of epidural morphine. Anesthesiology, 56, 431-436 (1982).
26. Saiah M, Borgeat A, Wilder-Smith OH, Rifat K, Suter PM. Epidural-morphine-induced pruritus: propofol versus naloxone. Anesth. Analg., 78, 1110-1113 (1994).
27. Ko MC, Song MS, Edwards T, Lee H, Naughton NN. The role of central mu opioid receptors in opioid-induced itch in primates. J. Pharmacol. Exp. Ther., 310, 169-176 (2004).
28. Thomas DA, Williams GM, Iwata K, Kenshalo DR Jr, Dubner R. The medullary dorsal horn. A site of action of morphine in producing facial scratching in monkeys. Anesthesiology, 79, 548-554 (1993).
29. Heyer G, Dotzer M, Diepgen TL, Handwerker HO. Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis. Pain, 73, 239-243 (1997).
30. Peer G, Kivity S, Agami O, Fireman E, Silverberg D, Blum M, Iaina A. Randomised crossover trial of naltrexone in uraemic pruritus. Lancet, 348, 1552-1554 (1996).
31. Bergasa NV. The pruritus of cholestasis. J. Hepatol., 43, 1078-1088 (2005).
32. Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. J. Am. Acad. Dermatol., 63, 680-688 (2010).
33. McRae CA, Prince MI, Hudson M, Day CP, James OF, Jones DE. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology, 125, 591-596 (2003).
34. Ko MC, Husbands SM. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J. Pharmacol. Exp. Ther., 328, 193-200 (2009).
35. Togashi Y, Umeuchi H, Okano K, Ando N, Yoshizawa Y, Honda T, Kawamura K, Endoh T, Utsumi J, Kamei J, Tanaka T, Nagase H. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820. Eur. J. Pharmacol., 435, 259-264 (2002).
36. Wikström B, Gellert R, Ladefoged SD, Danda Y, Akai M, Ide K, Ogasawara M, Kawashima Y, Ueno K, Mori A, Ueno Y. Kappaopioid system in uremic pruritus: multicenter, randomized, doubleblind, placebo-controlled clinical studies. J. Am. Soc. Nephrol., 16, 3742-3747 (2005).
37. Kumagai H, Ebata T, Takamori K, Muramatsu T, Nakamoto H, Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study. Nephrol. Dial. Transplant., 25, 1251-1257 (2010).
38. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature, 448, 700-703 (2007).
39. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science, 325, 1531-1534 (2009).
40. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, Ru F, Guan Y, Weng HJ, Geng Y, Undem BJ, Kollarik M, Chen ZF, Anderson DJ, Dong X. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell, 139, 1353-1365 (2009).
41. Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ. A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell, 106, 619-632 (2001).
42. Zylka MJ, Dong X, Southwell AL, Anderson DJ. Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc. Natl. Acad. Sci. U.S.A., 100, 10043-10048 (2003).
43. Handwerker HO, Schmelz M. Pain: itch without pain-a labeled line for itch sensation? Nat. Rev. Neurol., 5, 640-641 (2009).
44. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev., 86, 1309-1379 (2006).
45. Andoh T, Nagasawa T, Satoh M, Kuraishi Y. Substance P induction of itch-associated response mediated by cutaneous NK1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther., 286, 1140-1145 (1998).
46. Andoh T, Katsube N, Maruyama M, Kuraishi Y. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice. J. Invest. Dermatol., 117, 1621-1626 (2001).
47. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br. J. Dermatol., 122, 745-750 (1990).
48. Wallengren J, Möller H, Ekman R. Occurrence of substance P, vasoactive intestinal peptide, and calcitonin gene-related peptide in dermographism and cold urticaria. Arch. Dermatol. Res., 279, 512-515 (1987).
49. Chan J, Smoller BR, Raychauduri SP, Jiang WY, Farber EM, Chan C. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch. Dermatol. Res., 289, 611-616 (1997).
50. Hägermark O, Hökfelt T, Pernow B. Flare and itch induced by substance P in human skin. J. Invest. Dermatol., 71, 233-235 (1978).
51. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS, Petersen LJ, Schmelz M. Acute effects of substance P and calcitonin gene-related peptide in human skin - a microdialysis study. J. Invest. Dermatol., 115, 1015-1020 (2000).
52. Costa SK, Starr A, Hyslop S, Gilmore D, Brain SD. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom. Vascul. Pharmacol., 45, 209-214 (2006).
53. Duval A, Dubertret L. Aprepitant as an antipruritic agent? N. Engl. J. Med., 361, 1415-1416 (2009).
54. Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS ONE, 5, e10968 (2010).
55. Zhuo M. Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol. Brain, 2, 4 (2009).
56. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science, 288, 1765-1769 (2000).
57. Ikoma A, Rukwied R, Ständer S, Steinhoff M, Miyachi Y, Schmelz M. Neuronal sensitization for histamine-induced itch in lesional skin of patients with atopic dermatitis. Arch. Dermatol., 139, 1455-1458 (2003).
58. Bohm-Starke N, Hilliges M, Falconer C, Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol. Obstet. Invest., 46, 256-260 (1998).
59. Kinkelin I, Mötzing S, Koltenzenburg M, Bröcker EB. Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res., 302, 31-37 (2000).
60. Urashima R, Mihara M. Cutaneous nerves in atopic dermatitis. A histological, immunohistochemical and electron microscopic study. Virchows Arch., 432, 363-370 (1998).
61. Schmelz M, Hilliges M, Schmidt R, Ørstavik K, Vahlquist C, Weidner C, Handwerker HO, Torebjörk HE. Active "itch fibers" in chronic pruritus. Neurology, 61, 564-566 (2003).
62. Ikoma A, Fartasch M, Heyer G, Miyachi Y, Handwerker H, Schmelz M. Painful stimuli evoke itch in patients with chronic pruritus: central sensitization for itch. Neurology, 62, 212-217 (2004).
63. Baron R, Schwarz K, Kleinert A, Schattschneider J, Wasner G. Histamine-induced itch converts into pain in neuropathic hyperalgesia. Neuroreport, 12, 3475-3478 (2001).
64. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am. J. Med., 122 (Suppl.), S22-S32 (2009).
65. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem., 271, 5768-5776 (1996).
66. Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J. Pharmacol. Sci., 100, 471-486 (2006).
67. Scheinfeld N. The role of gabapentin in treating diseases with cutaneous manifestations and pain. Int. J. Dermatol., 42, 491-495 (2003).
68. Winhoven SM, Coulson IH, Bottomley WW. Brachioradial pruritus: response to treatment with gabapentin. Br. J. Dermatol., 150, 786-787 (2004).
69. Yesudian PD, Wilson NJ. Efficacy of gabapentin in the management of pruritus of unknown origin. Arch. Dermatol., 141, 1507-1509 (2005).
70. Porzio G, Aielli F, Verna L, Porto C, Tudini M, Cannita K, Ficorella C. Efficacy of pregabalin in the management of cetuximabrelated itch. J. Pain Symptom Manage., 32, 397-398 (2006).